chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: received a half dose booster without completing a primary vaccination series; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a half dose booster without completing a primary vaccination series) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE. Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE. Concurrent medical conditions included Psychiatric disorder NOS.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a half dose booster without completing a primary vaccination series). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a half dose booster without completing a primary vaccination series) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information was provided. The facility thought that the patient never got the primary series. So the patient possibly received a half dose booster without completing a primary vaccination series.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Product storage error; Moderna COVID-19 vaccine was administered to a patient from a vial that was open for more than 12 hours; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to a patient from a vial that was open for more than 12 hours) and PRODUCT STORAGE ERROR (Product storage error) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer on 16-Apr-2021 and Pfizer on 07-May-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 28-Mar-2022 at 10:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2022 at 10:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to a patient from a vial that was open for more than 12 hours). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to a patient from a vial that was open for more than 12 hours) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications was provided by the reporter.  Patient did not experienced any symptoms and sat for 15-20 minutes.  Vial was initially stored in the refrigerator on 25 Mar 2022 and was first punctured on 26 Mar 2022 at 8 30 AM. Vial was stored post puncture at room temperature and did not undergo any temperature excursions. Total amount of time vial was exposed to room temperature was more than 24 hours in the range (8 degree to 25 degree Celsius which was equal to 46 degree to 77 degree Fahrenheit) and was for about 48 hours.  No treatment medications were provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Glossodynia, Neck pain, Pharyngeal swelling, Swollen tongue, Vaccination site pain
Clinical narrative: swollen tongue; swollen throat; pain around tongue; pain around neck; Arm pain around injection site; This spontaneous case was reported by an other caregiver and describes the occurrence of SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), GLOSSODYNIA (pain around tongue), NECK PAIN (pain around neck) and VACCINATION SITE PAIN (Arm pain around injection site) in a 48-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Mar-2022, the patient experienced SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), GLOSSODYNIA (pain around tongue), NECK PAIN (pain around neck) and VACCINATION SITE PAIN (Arm pain around injection site). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), GLOSSODYNIA (pain around tongue), NECK PAIN (pain around neck) and VACCINATION SITE PAIN (Arm pain around injection site) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No concomitant medications were reported. Patient was planning to go to emergency room for check-up for all the events.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired dose administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose administered) in an 87-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 060H21A and 060H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 29-Mar-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose administered) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was frozen and thawed on 29 Mar 2022 prior to administration to the patient.Patient have not reported any adverse reactions.Vial did not undergo any temperature excursions.  No treatment medications were provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Gait inability
Clinical narrative: could not walk; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (could not walk) in a 68-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     The patient's past medical history included Multiple sclerosis, Pain, Burning sensation NOS, Osteoarthritis, Numbness, Ache, Ankle fracture, Fall and Knee deformity NOS (Weak knees). Concurrent medical conditions included Weight gain (put on weight) and Balance impaired NOS. Concomitant products included PREGABALIN, MAGNESIUM CHLORIDE (SLO-MAG), MELOXICAM (MOLOXICAM) and FUROSEMIDE for an unknown indication.    On 09-Mar-2021, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced GAIT INABILITY (could not walk). At the time of the report, GAIT INABILITY (could not walk) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No Treatments were reported.
Sex: F
Vaccine: DTAP
Symptoms: Blister, Erythema, Limb mass, Pain in extremity, Pruritus
Clinical narrative: her arms were itchy; has a big lump on her arm; her arms got red; her arms got sore; arm was almost black; sores all over it; Initial information received on 17-Mar-2022 regarding an unsolicited valid serious case received from a consumer/non-health care professional.  This case involves an unknown age female patient who experienced her arms were itchy, has a big lump on her arm, her arms got red, her arms got sore, arm was almost black and sores all over it while receiving vaccine diphtheria, tetanus and acellular pertussis vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect diphtheria, tetanus and acellular pertussis vaccine Suspension for injection produced by unknown manufacturer (lot number and expiry date: not reported) via unknown route in unknown administration site as prophylactic vaccination. Information on batch number was requested.  On an unknown date, after an unknown latency, the patient received the vaccine and her arms were itchy (Pruritus) before she got in the house. Patient went to the hospital and her arms got red and sore (Erythema) (Pain in extremity). Patient's arm had a big lump (Limb mass) and her arm was almost black (Skin discolouration) with sores all over it (Blister). Patient went to the pharmacy afterwards and was told to put alcohol on it. Patient also saw her nurse practitioner. Patient went to hospital for 17 days, starting on 06-Sep-2019.   Action taken with diphtheria, tetanus and acellular pertussis vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the events (her arms were itchy, has a big lump on her arm, her arms got red, her arms got sore, arm was almost black, sores all over it).  At time of reporting, the outcome was unknown for all events.; Sender's Comments: Sanofi company comment dated 17-Mar-2022: This case concerns an unknown age female patient who experienced her arms were itchy, has a big lump on her arm, her arms got red, her arms got sore, arm was almost black and sores all over it after receiving vaccine diphtheria, tetanus and acellular pertussis vaccine. Time to onset of the event is unknown. Information regarding condition at the time of vaccination, Site of vaccination administration,  medical history, concomitant medication, would be needed to rule out the alternative etiology. Based on the reported information, the role of an individual vaccine cannot be assessed.
Sex: F
Vaccine: DTAP
Symptoms: Skin discolouration
Clinical narrative: her arms were itchy; has a big lump on her arm; her arms got red; her arms got sore; arm was almost black; sores all over it; Initial information received on 17-Mar-2022 regarding an unsolicited valid serious case received from a consumer/non-health care professional.  This case involves an unknown age female patient who experienced her arms were itchy, has a big lump on her arm, her arms got red, her arms got sore, arm was almost black and sores all over it while receiving vaccine diphtheria, tetanus and acellular pertussis vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect diphtheria, tetanus and acellular pertussis vaccine Suspension for injection produced by unknown manufacturer (lot number and expiry date: not reported) via unknown route in unknown administration site as prophylactic vaccination. Information on batch number was requested.  On an unknown date, after an unknown latency, the patient received the vaccine and her arms were itchy (Pruritus) before she got in the house. Patient went to the hospital and her arms got red and sore (Erythema) (Pain in extremity). Patient's arm had a big lump (Limb mass) and her arm was almost black (Skin discolouration) with sores all over it (Blister). Patient went to the pharmacy afterwards and was told to put alcohol on it. Patient also saw her nurse practitioner. Patient went to hospital for 17 days, starting on 06-Sep-2019.   Action taken with diphtheria, tetanus and acellular pertussis vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the events (her arms were itchy, has a big lump on her arm, her arms got red, her arms got sore, arm was almost black, sores all over it).  At time of reporting, the outcome was unknown for all events.; Sender's Comments: Sanofi company comment dated 17-Mar-2022: This case concerns an unknown age female patient who experienced her arms were itchy, has a big lump on her arm, her arms got red, her arms got sore, arm was almost black and sores all over it after receiving vaccine diphtheria, tetanus and acellular pertussis vaccine. Time to onset of the event is unknown. Information regarding condition at the time of vaccination, Site of vaccination administration,  medical history, concomitant medication, would be needed to rule out the alternative etiology. Based on the reported information, the role of an individual vaccine cannot be assessed.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, COVID-19, Dyspnoea, Dyspnoea exertional, Fatigue
Clinical narrative: Patient presents generalized fatigue for approximately one week.  Patient has associated sore throat, headaches and shortness of breath with exertion.  In the ER patient had a Temp of 101.6° was satting 95% on room air.  Patient tested positive for COVID-19 and was admitted as she did not feel comfortable going home.  Patient's urinalysis was significant for UTI.  Patient placed on ciprofloxacin for three days with lactobacillus as bowel prophylaxis.  Following day patient was doing well afebrile and ready to discharge home.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, SARS-CoV-2 test positive, Urinary tract infection, Urine analysis abnormal
Clinical narrative: Patient presents generalized fatigue for approximately one week.  Patient has associated sore throat, headaches and shortness of breath with exertion.  In the ER patient had a Temp of 101.6° was satting 95% on room air.  Patient tested positive for COVID-19 and was admitted as she did not feel comfortable going home.  Patient's urinalysis was significant for UTI.  Patient placed on ciprofloxacin for three days with lactobacillus as bowel prophylaxis.  Following day patient was doing well afebrile and ready to discharge home.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Cardiomegaly, Condition aggravated, Dyspnoea, Myocarditis
Clinical narrative: Upset stomach and fever with both doses. Diagnosed with myocarditis in March 2022
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion
Clinical narrative: Upset stomach and fever with both doses. Diagnosed with myocarditis in March 2022
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Tinnitus
Clinical narrative: This was my booster.  I received my first two pfizer shots in Feb. 2021, after which I developed tinnitus, but did not connect the tinnitus to the injections (onset was either not immediate or I was simply too dismissive of the idea, being pro-vaccine in mindset).  During the course of 2021, the tinnitus remained, but became more manageable.  So when I woke up early in the morning on the day after my booster, with my ears ringing much louder than ever, the connection to the shot seemed unmistakable and undeniable.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Electrocardiogram normal, Full blood count abnormal, Hypoxia
Clinical narrative: Pt presented with complaint of worsening shortness of breath.  He reports that he tested positive for COVID-19 on the 8th of December.  He has been doing well until the past few days.    He has noticed that over the past few days his oxygen levels dropped into the mid 80s with activity, and at rest.  At that time he decided come in for further evaluation.  In triage patient was hypoxic and placed on nasal cannula oxygen. He was given decadron an d IV fluids. Tachycardia improved after fluids given. EKG stable. CBC elevated however Covid markers are trending down. Patient is stable for discharge home. He was prescribed Tussinex  10-8 MG/5ML ,ascorbic acid 250 MG tablet, Dexamethasone 6 MG tablet, vitamin D3 25 MCG (1000 UT) tablet, zinc sulfate 220 MG capsule, ProAir HFA 108 (90 BASE) MCG/ACT HFA inhaler., benzonatate 100 MG capsule, 4 L nasal cannula.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, SARS-CoV-2 test positive, Tachycardia
Clinical narrative: Pt presented with complaint of worsening shortness of breath.  He reports that he tested positive for COVID-19 on the 8th of December.  He has been doing well until the past few days.    He has noticed that over the past few days his oxygen levels dropped into the mid 80s with activity, and at rest.  At that time he decided come in for further evaluation.  In triage patient was hypoxic and placed on nasal cannula oxygen. He was given decadron an d IV fluids. Tachycardia improved after fluids given. EKG stable. CBC elevated however Covid markers are trending down. Patient is stable for discharge home. He was prescribed Tussinex  10-8 MG/5ML ,ascorbic acid 250 MG tablet, Dexamethasone 6 MG tablet, vitamin D3 25 MCG (1000 UT) tablet, zinc sulfate 220 MG capsule, ProAir HFA 108 (90 BASE) MCG/ACT HFA inhaler., benzonatate 100 MG capsule, 4 L nasal cannula.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Exposure to SARS-CoV-2, Full blood count, Laboratory test, Liver function test
Clinical narrative: November 24 and potentially the day before I started to develop hives after physical touch or friction to skin. Initial hives on hands where nitrile gloves rub when removing between thumb and pointer finder on the top of my hand. Then area that had small itches and no hives prior to itching/scratching turned into red irritated hives by simply scratching an itch. Seams of pants and tags left welts or hives. Began to improve. Initially didn?t recognize that it worsened after COVID exposure end of December, but I never tested positive or had respiratory symptoms. Saw the dermatologist at a dermatology office. Recommended taking up to 60mg of Zyrtec daily. Started with 20 and not improvement and then 30mg. Took 40-50mg most days. Traveled out of area hoping time off and vacation would improve it. Worse or the same. Contacted allergist. Recommended reporting. Will add Pepcid to 40mg of Zyrtec and give more time.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin irritation, Urticaria
Clinical narrative: November 24 and potentially the day before I started to develop hives after physical touch or friction to skin. Initial hives on hands where nitrile gloves rub when removing between thumb and pointer finder on the top of my hand. Then area that had small itches and no hives prior to itching/scratching turned into red irritated hives by simply scratching an itch. Seams of pants and tags left welts or hives. Began to improve. Initially didn?t recognize that it worsened after COVID exposure end of December, but I never tested positive or had respiratory symptoms. Saw the dermatologist at a dermatology office. Recommended taking up to 60mg of Zyrtec daily. Started with 20 and not improvement and then 30mg. Took 40-50mg most days. Traveled out of area hoping time off and vacation would improve it. Worse or the same. Contacted allergist. Recommended reporting. Will add Pepcid to 40mg of Zyrtec and give more time.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient given Moderna COVID vaccine which is only indicated for 18 years of age and older. No symptoms reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Continuous ringing in both ears
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: Moderna COVID vaccine given which is only indicated at 18 years of age or older. Patient experienced a sore arm and fatigue for one day, then resolved and well.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure congestive, Condition aggravated, Cough, Dyspnoea
Clinical narrative: The patient is a 83 y male presenting to the ED for monoclonal antibody infusion for treatment of COVID-19. The patient recently had a prolonged hospitalization at an ICU for a CHF exacerbation. Family reports that the patient was discharged 10/09/2021 and began developing symptoms like cough and increase in secretions. The family denies the patient being hypoxic and states that the patient's work of breathing is at baseline. They report that the patient tested positive for COVID-19 and the patient is present to receive the monoclonal antibody infusion treatment for COVID-19. At this time the patient and his family voice no additional complaints.  on 10/13/21. patient had progressive worsening of dyspnea, productive cough, and fevers 101.9 F. Bumex given by family at home over concern of possible CHF exacerbation however his symptoms did not abate. Brought to ED for further evaluation. Transferred to the ICU and placed on BiPap. Also started on vasopressors. 10/15 remains in ICU. Off pressors. Weaned to nasal cannula 10/16 intubated 10/18 PT remains in ICU on the vent and with sedation. Continues on IV abx. 10/19 continues in ICU, remains on the vent and sedation. abx d/c'd. 10/20  continues on the vent, weaning sedation 10/21 Continues in ICU currently. Remains on the vent, on vasopressors. C. Diff sent. 10/22 continues on the vent, tolerating CPAP. Weaning off pressors. 10/24 extubated to BiPAp 10/25 remains in ICU at this time. Continues on BiPap 10/26 continues in ICU at this time, tolerating nasal cannula, subsequently discharged.  Patient was readmitted multiple times after this initial hospitalization for respiratory failure along with other comorbidities.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, Increased bronchial secretion, Intensive care, Mechanical ventilation, Multimorbidity
Clinical narrative: The patient is a 83 y male presenting to the ED for monoclonal antibody infusion for treatment of COVID-19. The patient recently had a prolonged hospitalization at an ICU for a CHF exacerbation. Family reports that the patient was discharged 10/09/2021 and began developing symptoms like cough and increase in secretions. The family denies the patient being hypoxic and states that the patient's work of breathing is at baseline. They report that the patient tested positive for COVID-19 and the patient is present to receive the monoclonal antibody infusion treatment for COVID-19. At this time the patient and his family voice no additional complaints.  on 10/13/21. patient had progressive worsening of dyspnea, productive cough, and fevers 101.9 F. Bumex given by family at home over concern of possible CHF exacerbation however his symptoms did not abate. Brought to ED for further evaluation. Transferred to the ICU and placed on BiPap. Also started on vasopressors. 10/15 remains in ICU. Off pressors. Weaned to nasal cannula 10/16 intubated 10/18 PT remains in ICU on the vent and with sedation. Continues on IV abx. 10/19 continues in ICU, remains on the vent and sedation. abx d/c'd. 10/20  continues on the vent, weaning sedation 10/21 Continues in ICU currently. Remains on the vent, on vasopressors. C. Diff sent. 10/22 continues on the vent, tolerating CPAP. Weaning off pressors. 10/24 extubated to BiPAp 10/25 remains in ICU at this time. Continues on BiPap 10/26 continues in ICU at this time, tolerating nasal cannula, subsequently discharged.  Patient was readmitted multiple times after this initial hospitalization for respiratory failure along with other comorbidities.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Productive cough, Pyrexia, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: The patient is a 83 y male presenting to the ED for monoclonal antibody infusion for treatment of COVID-19. The patient recently had a prolonged hospitalization at an ICU for a CHF exacerbation. Family reports that the patient was discharged 10/09/2021 and began developing symptoms like cough and increase in secretions. The family denies the patient being hypoxic and states that the patient's work of breathing is at baseline. They report that the patient tested positive for COVID-19 and the patient is present to receive the monoclonal antibody infusion treatment for COVID-19. At this time the patient and his family voice no additional complaints.  on 10/13/21. patient had progressive worsening of dyspnea, productive cough, and fevers 101.9 F. Bumex given by family at home over concern of possible CHF exacerbation however his symptoms did not abate. Brought to ED for further evaluation. Transferred to the ICU and placed on BiPap. Also started on vasopressors. 10/15 remains in ICU. Off pressors. Weaned to nasal cannula 10/16 intubated 10/18 PT remains in ICU on the vent and with sedation. Continues on IV abx. 10/19 continues in ICU, remains on the vent and sedation. abx d/c'd. 10/20  continues on the vent, weaning sedation 10/21 Continues in ICU currently. Remains on the vent, on vasopressors. C. Diff sent. 10/22 continues on the vent, tolerating CPAP. Weaning off pressors. 10/24 extubated to BiPAp 10/25 remains in ICU at this time. Continues on BiPap 10/26 continues in ICU at this time, tolerating nasal cannula, subsequently discharged.  Patient was readmitted multiple times after this initial hospitalization for respiratory failure along with other comorbidities.
Sex: U
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: Describe Event, Problem, or Product Use Error: [Moderna] use for COVID-19 under Emergency Use Authorization (EUA): per hospital record patient Received his primary Moderna vaccination at this location and is in his chart but not showing up on the immunization registry
Sex: U
Vaccine: HEPA
Symptoms: Underdose
Clinical narrative: Per hospital report patient received pediatric dose of Hepatitis A in place of Adult dose
Age: 26.0
Sex: M
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Per hospital report Patient in office visit on date listed above with Dr. Hep A vaccine was ordered and administered to the patient before immunization was due. No harm noted, patient notified and instructed that he will need another HEP A booster in 6 months per Dr.
Sex: F
Vaccine: FLUX
Symptoms: Extra dose administered
Clinical narrative: Per hospital report during rooming process patient states "i need a flu shot too.i haven't had one in a few years" after flu vaccine was administered it was noted in patients chart that she received flu vaccine in September 2021. called placed to patient to notify her of the above, no answer.generic message left asking patient to return call to this writer here in the clinic
Sex: U
Vaccine: HEPA
Symptoms: Incorrect dose administered
Clinical narrative: Per hospital report patient received pediatric dose of Hepatitis A in place of Adult dose of Hepatitis A
Sex: U
Vaccine: DTAP
Symptoms: Injection site mass
Clinical narrative: Per hospital report Patient received 3 immunizations on 2/9/22. Had vaccination reaction (lump on thigh) and was seen on 2/18/22. It was at that time that it was discovered that the vaccines were never documented in the patient chart and the visit was still open with vaccines pending. Patient was again seen on 2/23/22 and this had not been resolved.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Malaise, Nasal congestion
Clinical narrative: I got COVID my symptoms was nasal congestion, cough and extreme fatigue. I was sent to Hospital for the Monoclonal antibodies for Omicron within 24 hours my symptoms had subsided.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I got COVID my symptoms was nasal congestion, cough and extreme fatigue. I was sent to Hospital for the Monoclonal antibodies for Omicron within 24 hours my symptoms had subsided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Extra dose administered, Feeling hot, Injection site pain, Musculoskeletal stiffness
Clinical narrative: Some soreness at the top of my left arm and both hands felt hot and stiff . I kept waking up and rubbing my hands as they felt very stiff.  If I touched my face with either hand they felt hot.  They were fine when I woke up but still a little stiff.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: Some soreness at the top of my left arm and both hands felt hot and stiff . I kept waking up and rubbing my hands as they felt very stiff.  If I touched my face with either hand they felt hot.  They were fine when I woke up but still a little stiff.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tennitus:  Loud and constant ringing in ears.  Onset shortly after vaccine injection, have never experienced this before.  Has not subsided.  Will seek medical help.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy
Clinical narrative: Swollen axillary lymph nodes right arm, fatigue
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test abnormal, Computerised tomogram abnormal, Condition aggravated, Lung operation, Lymphadenopathy
Clinical narrative: 09/17/2021 I noticed lymph notes. Had a CT and then  they wanted me to have a  Pet Scan.  Cancer had returned. Then had lung surgery in December of 2021.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Neoplasm malignant, Positron emission tomogram abnormal
Clinical narrative: 09/17/2021 I noticed lymph notes. Had a CT and then  they wanted me to have a  Pet Scan.  Cancer had returned. Then had lung surgery in December of 2021.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Aphonia, Burning sensation, C-reactive protein increased, COVID-19
Clinical narrative: So on Aug. 4th, I lost my voice and it had been gone for almost two days, I decided to COVID test and it was positive. The following day, I had a severe headache that lasted about six hours. I had severe fatigue for about three days, and I never had very bad pulmonary symptoms. I did experience brain fog and difficulty word finding. Three weeks after the initial infection I began having burning sensation on my arm. As of March 2, 2022, the brain fog and burning sensation has not subsided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal
Clinical narrative: So on Aug. 4th, I lost my voice and it had been gone for almost two days, I decided to COVID test and it was positive. The following day, I had a severe headache that lasted about six hours. I had severe fatigue for about three days, and I never had very bad pulmonary symptoms. I did experience brain fog and difficulty word finding. Three weeks after the initial infection I began having burning sensation on my arm. As of March 2, 2022, the brain fog and burning sensation has not subsided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Nerve conduction studies normal, Red blood cell sedimentation rate increased, SARS-CoV-2 test positive
Clinical narrative: So on Aug. 4th, I lost my voice and it had been gone for almost two days, I decided to COVID test and it was positive. The following day, I had a severe headache that lasted about six hours. I had severe fatigue for about three days, and I never had very bad pulmonary symptoms. I did experience brain fog and difficulty word finding. Three weeks after the initial infection I began having burning sensation on my arm. As of March 2, 2022, the brain fog and burning sensation has not subsided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Condition aggravated, Fatigue, Feeling cold, Laboratory test
Clinical narrative: pt c/o worsening migraines, fatigue, extreme cold, small bowel obstruction
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Small intestinal obstruction
Clinical narrative: pt c/o worsening migraines, fatigue, extreme cold, small bowel obstruction
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Gait inability, Hypoaesthesia, Malaise, Paralysis, Urinary incontinence
Clinical narrative: After 48 hours of the vaccine, patient was very ill, she could not walk, both legs are numb, and experienced urinary incontinence. She is partially paralyzed from the vaccine. Right now, she is seeing physical therapy to help her recovery from normal daily activities.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cardiac failure congestive, Cough, Dyspnoea
Clinical narrative: Presented with cough, SOB x 1 week; + covid PTA at SNF; Spo2 89% in ED; Admit 9/20 to tele with Covid PNA and CHF exacerbation; 9/20 steroids, singulair, zinc started, O2 @ 2 LPM; 9/21 remdesivir, Vit C, Vit D3 started; 9/22 o2 @ RA; 9/24 dc to SNF on RA
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented with cough, SOB x 1 week; + covid PTA at SNF; Spo2 89% in ED; Admit 9/20 to tele with Covid PNA and CHF exacerbation; 9/20 steroids, singulair, zinc started, O2 @ 2 LPM; 9/21 remdesivir, Vit C, Vit D3 started; 9/22 o2 @ RA; 9/24 dc to SNF on RA
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Blood creatinine increased, COVID-19 pneumonia, General physical health deterioration, Malaise
Clinical narrative: Presented with Covid symptoms; dx PTA on 9/2 and hospitalized from 9/2-9/9..had been improving but then worsened over last few days; admitted 9/23 to tele with Covid PNA; 9/23 zithromax, rocephin, Vit C, zinc started; 9/24 Baricitinib, steroids, lovenox started 9/29 maxipime started; O2 flucuated between 5lPM on arrival to NRB on 10/2; 10/2 Cr rising; nephrology consult; appearing headed to multiorgan failure; pt decided on comfort care/hospice;
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, COVID-19, COVID-19 pneumonia, Cardiac failure congestive
Clinical narrative: Presented  with SOB; Admitted 9/26 to medical with CHF exac and Covid PNA; tx with zinc, singulair, steroids, O2 @ 2 LPM initially COVID-19 Pneumonia with acute hypoxic respiratory failure and without sepsis Patient presented with SOB and hypoxia and tested positive for COVID on 9/26, symptom onset for several weeks. Patient placed in airborne isolation and started on supportive care as below.Stable at the time of dc. Admission O2 needs: 2 LPM via NC Current O2 Needs:none, adequate sats on RA Zinc / Singulair / Antitussives received while in house  Steroids: Dexamethasone  (6mg daily) - to complete upon dc  Remdesivir: Deferred due to timing of onset of symptoms Convalescent Plasma: Deferred due to timing of onset of symptoms Tocilizumab: Deferred due to limited O2 needs or lack of cytokine storm Anticoagulation: On eliquis
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Presented  with SOB; Admitted 9/26 to medical with CHF exac and Covid PNA; tx with zinc, singulair, steroids, O2 @ 2 LPM initially COVID-19 Pneumonia with acute hypoxic respiratory failure and without sepsis Patient presented with SOB and hypoxia and tested positive for COVID on 9/26, symptom onset for several weeks. Patient placed in airborne isolation and started on supportive care as below.Stable at the time of dc. Admission O2 needs: 2 LPM via NC Current O2 Needs:none, adequate sats on RA Zinc / Singulair / Antitussives received while in house  Steroids: Dexamethasone  (6mg daily) - to complete upon dc  Remdesivir: Deferred due to timing of onset of symptoms Convalescent Plasma: Deferred due to timing of onset of symptoms Tocilizumab: Deferred due to limited O2 needs or lack of cytokine storm Anticoagulation: On eliquis
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Convalescent plasma transfusion, Diarrhoea, Dyspnoea, Intensive care
Clinical narrative: Presented with SOB, diarrhea x 3 days; admit 9/19 to ICU with Covid PNA; 9/19 maxipime, steroids, singulair, zinc started, 15 NRB O2, ? Convalescent plasma (I'm thinking she did not get it)Documentation on FFP is contradictory but it does appear in final procedure coding.; 9/23 worsening kidney and resp function; family decided on comfort care
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary function test decreased, Renal impairment
Clinical narrative: Presented with SOB, diarrhea x 3 days; admit 9/19 to ICU with Covid PNA; 9/19 maxipime, steroids, singulair, zinc started, 15 NRB O2, ? Convalescent plasma (I'm thinking she did not get it)Documentation on FFP is contradictory but it does appear in final procedure coding.; 9/23 worsening kidney and resp function; family decided on comfort care
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Hypoxia, Nausea, Presyncope
Clinical narrative: Presented with n/v, near syncope, cough; + Covid in ED; Admit 9/18 to  medical with Covid infection, hypoxia; tx with steroids, merrem, Vit C, Symbicort, Vit D3, heparin (sq), singulair, zinc (all started 9/18); O2 @ 2 LPM on admission; remains on O2 @ 2 LPM at d/c
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Presented with n/v, near syncope, cough; + Covid in ED; Admit 9/18 to  medical with Covid infection, hypoxia; tx with steroids, merrem, Vit C, Symbicort, Vit D3, heparin (sq), singulair, zinc (all started 9/18); O2 @ 2 LPM on admission; remains on O2 @ 2 LPM at d/c
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cough, Hyperglycaemia, SARS-CoV-2 test positive
Clinical narrative: Presented with non-productive cough x1 day, hyperglycemia; + covid in ED: Admit 9/26 to tele with covid PNA, hyperglycemia; Tx with singulair, zinc starting on 9/26; primarily treated for hyperglycemia; O2  at RA throughout stay
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Interchange of vaccine products
Clinical narrative: A participant presented at clinic requesting to get a first dose of Pfizer and was registered on site.   After the participant received the Pfizer vaccination, upon review of his appointment in the Database, it was discovered that he had received 9 doses of Pfizer and 1 dose of JNJ at the clinic. A check verified database information and an additional 4 doses of JNJ and 1 Moderna outside of clinic was also identified as well as 2 influenza vaccines. The participant denied receiving multiple doses of vaccine.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Breast mass, Burning sensation, Injection site pain, Limb discomfort, Lymphadenopathy
Clinical narrative: I felt a very sharp and burning sensation from the area where I received the vaccine. It went to my left breast up to my nipple. The same day my lymph nodes began to swell under my armpits, Left jaw, and neck. My left arm was very heavy. I could not extend it above my head. That lasted for months. To the point where they found a lump under my breast. I ended up having a mammogram in August 2021, which were negative. You could feel the lump but there was nothing to be over concerned for. They prescribed me Toradol. It caused me a lot of anxiety. I am a nurse and I have received many immunizations and this reaction lasted a long time.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Mammogram normal, Mobility decreased
Clinical narrative: I felt a very sharp and burning sensation from the area where I received the vaccine. It went to my left breast up to my nipple. The same day my lymph nodes began to swell under my armpits, Left jaw, and neck. My left arm was very heavy. I could not extend it above my head. That lasted for months. To the point where they found a lump under my breast. I ended up having a mammogram in August 2021, which were negative. You could feel the lump but there was nothing to be over concerned for. They prescribed me Toradol. It caused me a lot of anxiety. I am a nurse and I have received many immunizations and this reaction lasted a long time.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Feeling abnormal, SARS-CoV-2 test positive, Sternal injury
Clinical narrative: On 12/26/21 I started with a dry cough. I do not think I ever had a fever, I just felt bad. ON 12/27/21 I got tested and on 12/29/21 I was informed that I tested positive for Covid 19. On 01/08/22 I took a Covid test and I was still positive.  On 01/11/22 I went to doctor and was given medicine for my cough and was advised to keep taking Mucinex. On 01/13/22 from coughing so much I ended up damaging my sternum and had to go to the urgent care. Urgent care may have prescribed me steroids and antibiotics. Once I started taking the steroids and antibiotics, I noticed the next day I felt better. The cough continued to lingered for about another 2 weeks. I still have brain fog today.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram normal, Condition aggravated, Immunisation reaction, Laboratory test normal, Paraesthesia
Clinical narrative: Patient has a history of Guillain-Barre Syndrome dating back to the late 90's. Patient reports that there was some debate between his providers as to whether or not he should get the COVID vaccine. However, after contracting COVID, providers agreed that it he should receive the vaccine.  Patient reports that he received his first dose on 2/15/2022 at Health Services and within a week developed paresthesia around his nose and upper lip which he reports subsided in 3 days. On 3/10/2022, the patient went back to receive his 2nd dose. On the evening on 3/21/2022, patient reports that he noticed a tingle in the same area around his nose and upper lip that wouldn't go away. On the morning of 3/22/2022, he presented to the ER. While at the ER, he reports that he say several providers as well as a Neurology fellow. He obtained multiple labs and a CT scan that resulted as normal. After deliberation, the team agreed that the reaction was attributed to the Pfizer COVID vaccine.   As of 3/31/202, patient reports that he is still experiencing the tingling sensation which has not subsided.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Patient has a history of Guillain-Barre Syndrome dating back to the late 90's. Patient reports that there was some debate between his providers as to whether or not he should get the COVID vaccine. However, after contracting COVID, providers agreed that it he should receive the vaccine.  Patient reports that he received his first dose on 2/15/2022 at Health Services and within a week developed paresthesia around his nose and upper lip which he reports subsided in 3 days. On 3/10/2022, the patient went back to receive his 2nd dose. On the evening on 3/21/2022, patient reports that he noticed a tingle in the same area around his nose and upper lip that wouldn't go away. On the morning of 3/22/2022, he presented to the ER. While at the ER, he reports that he say several providers as well as a Neurology fellow. He obtained multiple labs and a CT scan that resulted as normal. After deliberation, the team agreed that the reaction was attributed to the Pfizer COVID vaccine.   As of 3/31/202, patient reports that he is still experiencing the tingling sensation which has not subsided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Laboratory test normal
Clinical narrative: 1/10/22 significant hypertension diagnosed during unrelated orthopedic visit:  193/108.   Bought an at-home BP monitor and followed up with high BP readings on 1/17 and 1/18/22:  187/100,  205/94;   after 200/95 on 1/19/22, unable to reach primary care provider, so I went to the local ER:  219/109.   No chest pain or headache, no symptoms of stroke.  Started Amlodipine 5mg,  increased to 10mg on 1/31/22 with BP gradually coming down, highest 169/83.  Current range:  126/76 to 148/78.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: On 3/30/2022 at 1:40 pm patient came into clinic for a booster dose 0.25mL of Moderna and was inadverdently given a full 0.5mL dose of Moderna. Outdated material was reviewed and dose verified by another nurse before injection given. Updated material has since replaced outdated material. Moderna and DON was notified of the incidient . Patient has been notified and will be monitiered for the next seven days according to Moderna recommendation.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy colon, Colonoscopy abnormal, Gastrointestinal disorder, Gastrointestinal haemorrhage, Gastrointestinal mucosa hyperaemia
Clinical narrative: Patient admitted for GI bleed - he received 4 units PRBC.  Colonoscopy 2/15/22 - there was marked increased erythema, swelling, friability, and ulceration associated with the floor of the cecum and along the cecal side of the ileocecal valve.  Multiple biopsies were obtained from this area and sent for pathology review. Discharged to home. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Intestinal ulcer, Oedema mucosal, Red blood cell transfusion
Clinical narrative: Patient admitted for GI bleed - he received 4 units PRBC.  Colonoscopy 2/15/22 - there was marked increased erythema, swelling, friability, and ulceration associated with the floor of the cecum and along the cecal side of the ileocecal valve.  Multiple biopsies were obtained from this area and sent for pathology review. Discharged to home. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: N/A.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Appendicitis
Clinical narrative: Patient hospitalized for acute appendicitis within 6 weeks of receiving covid vaccination.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram abnormal, Anticoagulant therapy, Arterial angioplasty, Bunion operation, Iliac artery disease
Clinical narrative: PAtient presented to the ED on 12/21/21 for right great toe infection. Vascular surgery was consulted due to CT angio aorta abd through bilateral lower extremity showing right popliteal artery occlusion (left common iliac artery diseased with at least 50% stenosis through the external iliac artery). Vascular (Dr. ) performed right thigh cutdown for angioaccess to bypass graft; right runoff angiogram; balloon angioplasty of popliteal to ATA. She was started on heparin gtt until her INR was therapeutic above 2 on warfarin. ID was consulted on 12/22/21 and recommended antibiotic therapy until discharge (prescribed ceftriaxone 12/21, then transitioned to cefazolin from 12/22-12/29). Patient underwent right first toe amputation, silver bunionectomy on 12/23/21 with Dr. of podiatry. Discharged to step down. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Iliac artery stenosis, International normalised ratio increased, Localised infection, Peripheral artery occlusion, Toe amputation
Clinical narrative: PAtient presented to the ED on 12/21/21 for right great toe infection. Vascular surgery was consulted due to CT angio aorta abd through bilateral lower extremity showing right popliteal artery occlusion (left common iliac artery diseased with at least 50% stenosis through the external iliac artery). Vascular (Dr. ) performed right thigh cutdown for angioaccess to bypass graft; right runoff angiogram; balloon angioplasty of popliteal to ATA. She was started on heparin gtt until her INR was therapeutic above 2 on warfarin. ID was consulted on 12/22/21 and recommended antibiotic therapy until discharge (prescribed ceftriaxone 12/21, then transitioned to cefazolin from 12/22-12/29). Patient underwent right first toe amputation, silver bunionectomy on 12/23/21 with Dr. of podiatry. Discharged to step down. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.